MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

Latest S-3/A SEC Filings
Registration statement under Securities Act of 1933: [Amend]

ALBANY MOLECULAR RESEARCH INC, S-3/A, 2000-09-15
CYANOTECH CORP, S-3/A, 2000-08-10
MAXIM PHARMACEUTICALS INC, S-3/A, 2000-02-17
MAXIM PHARMACEUTICALS INC, S-3/A, 2000-02-04
MAXIM PHARMACEUTICALS INC, S-3/A, 2000-01-07
MAXIM PHARMACEUTICALS INC, S-3/A, 1999-09-20
MAXIM PHARMACEUTICALS INC, S-3/A, 1999-08-30
UNIGENE LABORATORIES INC, S-3/A, 1998-11-04
UNIGENE LABORATORIES INC, S-3/A, 1998-10-21
TWINLAB CORP, S-3/A, 1998-04-03
TWINLAB CORP, S-3/A, 1998-03-20
LYNX THERAPEUTICS INC, S-3/A, 1997-12-31
BIO TECHNOLOGY GENERAL CORP, S-3/A, 1997-09-22
NAPRO BIOTHERAPEUTICS INC, S-3/A, 1997-09-09
NAPRO BIOTHERAPEUTICS INC, S-3/A, 1997-09-05
NAPRO BIOTHERAPEUTICS INC, S-3/A, 1997-08-18
UNIGENE LABORATORIES INC, S-3/A, 1997-01-10
UNIGENE LABORATORIES INC, S-3/A, 1996-09-17
UNIGENE LABORATORIES INC, S-3/A, 1996-06-28
UNIGENE LABORATORIES INC, S-3/A, 1996-06-19
BIO TECHNOLOGY GENERAL CORP, S-3/A, 1995-04-13
GENENTECH INC, S-3/A, 1995-04-03


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission